| Product Name | MF | CAS | Details |
|---|
| 2,6-Dihydroxybenzamide | C7H7NO3 | 3147-50-0 | Details |
| Methyl 2-[5-bromo-2-(chlorosulfonyl)phenyl]acetate | C9H8BrClO4S | 1403387-05-2 | Details |
| Neodymium(III) Chloride | Cl3Nd | 10024-93-8 | Details |
| Neu5GcAc[1Me,4789Ac]a(2-6)Gal[24Bz,3Bn]-b-MP | Details |
| 2-Amino-3-(1H-imidazol-1-yl)propanehydrazide dihydrochloride | 2287262-67-1 | Details |
| (±)-1-(2-Furyl)ethanol | C6H8O2 | 4208-64-4 | Details |
| 1-(4-Phenoxyphenoxy)-2-propanol | C15H16O3 | 57650-78-9 | Details |
| 3-Methyl-4-(methylsulfonyl)benzoic acid | C9H10O4S | 1186663-65-9 | Details |
| N-(4-Chloro-2-nitrophenyl)-2,2-dimethylpropanamide | C11H13ClN2O3 | 150783-39-4 | Details |
| Sesamol-d2 | C7H6O3 | 923932-05-2 | Details |
| (Propan-2-yl)({[3-(pyridin-3-yl)-1,2,4-oxadiazol-5-yl]methyl})amine | C11H14N4O | 1184229-50-2 | Details |
| 5-[(3,4-Difluorophenyl)methyl]-1,2,4-oxadiazol-3-amine | C9H7F2N3O | 1504754-13-5 | Details |
| Methyl glycolate | C3H6O3 | 96-35-5 | Details |
| CD34 Blocking Peptide | Details |
| Ethyl ±-Bromo-2-phenylpropionate | C11H13BrO2 | 39149-82-1 | Details |
| Cytarabine hydrochloride - Bio-X ? | C9H14ClN3O5 | 69-74-9 | Details |
| 5-Formyl-2-methylbenzoic acid | C9H8O3 | 105650-34-8 | Details |
| 4-Aminobutyl 2-O-(a-D-mannopyranosyl)-a-D-mannopyranoside | C16H31NO11 | Details |
| Lysozyme antibody (Prediluted for IHC) | Details |
| 3,4-Dihydro-2H-1,5-benzodioxepin-7-ylmethylamine | C10H13NO2 | 23475-00-5 | Details |
| (R)-1-(3-Chlorophenyl)ethanamine HCl | C8H11Cl2N | 1167414-90-5 | Details |
| KCIP1 antibody | Details |
| Cefotaxime sodium impurity C | C17H17N5O8S2 | 66403-32-5 | Details |
| TRAPPC2L protein (His tag) | Details |
| 16-Mercaptohexadecanoic acid | C16H32O2S | 69839-68-5 | Details |
| MRS 2500 tetraammonium | C13H21IN6O8P2 | 630103-23-0 | Details |
| 2,5-Dihydroxyxanthone | C13H8O4 | 35040-32-5 | Details |
| H-Trp-Arg-OH·2 HCl | C17H26Cl2N6O3 | 276880-00-3 | Details |
| 1-Methyl-4,8-dioxa-1,10-diazaspiro[5.5]undecane | C8H16N2O2 | 2230803-23-1 | Details |
| Fmoc-L-Hyp-OH | C20H19NO5 | 88050-17-3 | Details |
| Methyl 2-(4-bromophenyl)-2-oxoacetate | C9H7BrO3 | 57699-28-2 | Details |
| Lefamulin acetate | C30H49NO7S | 1350636-82-6 | Details |
| Silymarin | C25H22O10 | 65666-07-1 | Details |
| 2-Amino-1-(2-methylpiperidin-1-yl)propan-1-one | C9H18N2O | 56414-90-5 | Details |
| SH3BP5 antibody | Details |
| Suptavumab | 1629615-23-1 | Details |
| Atidortoxumab | 1939108-95-8 | Details |
| FGF23 protein | Details |
| Porantherine | C15H23N | 33529-61-2 | Details |
| Azido myristic acid | C12H23N3O2 | 80667-36-3 | Details |
| (3R)-Tetrahydrofuran-3-yl 4-Methylbenzenesulfonate | C11H14O4S | 219823-47-9 | Details |
| (4-Hydroxymethyl-benzyl)-carbamic acid tert-butyl ester | C13H19NO3 | 123986-64-1 | Details |
| α-Chymotrypsinogen A from bovine pancreas | NULL | 9035-75-0 | Details |
| Pkcβii peptide inhibitor I trifluoroacetate salt | C61H94N12O19 | 862502-26-9 | Details |
| 2-Bromo-1-(4-hydroxy-3-methylphenyl)ethan-1-one | C9H9BrO2 | 41877-17-2 | Details |
| 2-(4-Aminocuban-1-yl)ethanol | C10H13NO | 2167127-13-9 | Details |
| MARVELD2 antibody | Details |
| KLHL18 antibody | Details |
| 3-{[Phenyl(pyridin-2-yl)methyl]amino}propan-1-ol | C15H18N2O | 626214-15-1 | Details |
| Hydroxy evodiamine | C19H17N3O2 | 1238-43-3 | Details |
| EGFR antibody | C107H179N35O36S7 | 205923-56-4 | Details |
| Allicin - Mixture of mainly diallyldisulfide and diallyl trisulfide | C6H10OS2 | 539-86-6 | Details |
| N-(3-Aminophenyl)butanamide hydrochloride | C10H15ClN2O | 1181458-24-1 | Details |
| BBS6 antibody | Details |
| Pyridoxine hydrochloride | C8H12ClNO3 | 58-56-0 | Details |
| Ac-SACRNLFG-NH2 | Details |
| [Pyr1]-apelin 13 Heavy | Details |
| 1H,2H,3H,4H-Cyclopenta[b]indol-2-one | C11H9NO | 150670-63-6 | Details |
| 1-Fmoc-4-(hydroxymethyl)piperidine | C21H23NO3 | 1072502-03-4 | Details |
| 1-Methyl-1-cyclohexanecarboxylic acid | C8H14O2 | 1123-25-7 | Details |
| 2,2,4(or 2,4,4)-Trimethyl-1,6-hexanediamine | C9H22N2 | 25513-64-8 | Details |
| NUBP1 antibody | Details |
| 1-(4-Ethynylphenyl)-2,2,2-trifluoroethan-1-ol | C10H7F3O | 1443429-33-1 | Details |
| Ethyl 2-ethylpyrrolidine-2-carboxylate | C9H17NO2 | 1549422-58-3 | Details |
| Deacetylanisomycin | C12H17NO3 | 27958-06-1 | Details |
| Pf-06412154 hydrochloride | C24H28ClN3O3 | 1421349-19-0 | Details |
| N-Methyl-N-(1-naphthyl)-2-iodobenzamide | C18H14INO | 74881-59-7 | Details |
| 1-{[2-(4-Chlorophenyl)-5-methyl-1,3-oxazol-4-yl]methyl}-N-(2,2-diethoxyethyl)piperidine-3-carboxamide | C23H32ClN3O4 | 901869-09-8 | Details |
| 1-[(4-aminophenyl)methyl]piperidin-4-ol | C12H18N2O | 262368-63-8 | Details |
| 2-tert-Butyl-4-iodo-1H-imidazole | C7H11IN2 | 1010835-79-6 | Details |
| 2-(2,3-Dihydro-1-benzofuran-3-yl)ethanimidamide hydrochloride | C10H13ClN2O | 1803600-01-2 | Details |
| Glutaredoxin3 protein (His tag) | Details |
| 4-Hydroxynaphthalene-1-carboxylic acid | C11H8O3 | 7474-97-7 | Details |
| 3-Methyl-6-(thiophen-2-yl)-4-(trifluoromethyl)thieno[2,3-b]pyridine-2-carboxylic acid | C14H8F3NO2S2 | 721893-48-7 | Details |
| 2-Aminobicyclo[3.1.0]hexane-2-carboxylic acid hydrochloride | C7H12ClNO2 | 2230807-75-5 | Details |
| Allyl 2,3-anhydro-4,6-O-benzylidene-a-L-mannopyranoside | Details |
| Ac-IAMVD-OH | Details |
| 3-(3-Bromo-4-fluorophenyl)-2-methylpropanoic acid | C10H10BrFO2 | 1251205-25-0 | Details |
| 1-(Pyridin-2-ylmethyl)-1H-pyrrole-2-carboxylic acid | C11H10N2O2 | 896049-13-1 | Details |
| 6-Bromo-7-methylquinoxaline | C9H7BrN2 | 646504-80-5 | Details |
| SmMLCKp, Smooth-Muscle Myosin Light-Chain Kinase (796-815), Calmodulin Binding | C98H169N39O25 | 120396-89-6 | Details |
| (1S)-5,7-Difluoro-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride | C10H12ClF2N | 1807940-93-7 | Details |
| 2-Chloro-N-(2,4,6-tribromophenyl)acetamide | C8H5Br3ClNO | 89892-46-6 | Details |
| 1-(1-Methyl-1H-imidazol-2-yl)pyrrolidine-3-carboxylic acid hydrochloride | C9H14ClN3O2 | 2044713-47-3 | Details |
| 3-[(2-Phenylethoxy)methyl]aniline | C15H17NO | 1039862-68-4 | Details |
| 4-(4-Ethylphenyl)-1,2,3,6-tetrahydropyridine hydrochloride | C13H18ClN | 92039-52-6 | Details |
| 3-[(4-Chloro-3-methylphenoxy)methyl]-4-methoxybenzoic acid | C16H15ClO4 | 438218-99-6 | Details |
| N-Retinylidene-N-retinylethanolamine TFA salt | C44H58F3NO3 | 1821308-73-9 | Details |
| (±)-Mevalonic acid-(methyl-d3) lithium | C6H12O4 | 52061-66-2 | Details |
| 2-Methoxyoctane | C9H20O | 1541-09-9 | Details |
| 4-(Hydroxymethyl)-3-methylbenzonitrile | C9H9NO | 227094-07-7 | Details |
| (2R)-2-[2-(1H-1,2,3,4-Tetrazol-1-yl)acetamido]propanoic acid | C6H9N5O3 | 1309010-67-0 | Details |
| RGS21 protein (His tag) | Details |
| 2-Fluoro-2-methylhexanoic acid | C7H13FO2 | 74106-60-8 | Details |
| SAPS3 antibody | Details |
| H-EIDQTPYK-OH | Details |
| (±)-Nicotine-d7 (N-methyl-d3 pyridine-d4) | C10H14N2 | 1219805-86-3 | Details |
| Bisphenol-A [2 EO] di-methacrylate | C27H32O6 | 24448-20-2 | Details |
| ENTPD7 antibody | Details |
| 3-(5-Chlorothiophen-2-yl)-1-phenyl-1H-pyrazole-4-carboxylic acid | C14H9ClN2O2S | 882228-95-7 | Details |
| Product Total： Product Page： | ||||
| 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 | ||||